Skip to content

It’s Wheezy Peasy! A Review of the GINA 2020 Updated Report for Asthma Management and Prevention

This activity is intended for ambulatory care pharmacists working as part of the health care team to develop appropriate and effective treatment plans for patients with asthma.

Asthma is a prevalent disease state that affects both inpatients and outpatients of all ages, and pharmacists can play a significant role in asthma management in both practice settings. Historically, short-acting beta-agonists (SABAs) have been used for patients with mild asthma as a reliever medication for intermittent asthma symptoms. Based on recent evidence in the literature, the Global Initiative for Asthma (GINA) now recommends the use of as-needed (PRN) inhaled corticosteroid-formoterol combination for patients with mild asthma instead of a SABA. Pharmacists can use this new evidence-based recommendation to encourage providers to initiate PRN ICS-formoterol early in patients with mild asthma.

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Apply the GINA asthma treatment algorithm and identify which patients qualify for mild, moderate, or severe asthma treatment
  • Evaluate the evidence supporting the use of PRN ICS-formoterol in patients with mild asthma
  • Construct a treatment plan for adults and adolescents with asthma


Katie Marti, PharmD is a PGY1 Pharmacy Resident at Baystate Medical Center in Springfield, MA. She graduated with her Doctor of Pharmacy degree from the University of Connecticut School of Pharmacy in 2020. Upon completion of her PGY1 residency, she hopes to obtain an inpatient clinical pharmacist position where she is able to keep up her skills in various clinical settings with diverse patient populations..

Free to MCPHS Alumni and full-time employees; $12.00 for all other professionals.


ACPE logo

Release Date: June 2, 2021
Expiration Date: June 2, 2022
Contact Hours: 1 (.10 CEU)
Universal Activity Number: 0026-0000-21-132-H01-P | Application-based
ACPE Topic Designator: Drug Therapy


Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this educational activity for a total of 1 contact hours (0.1 CEUs).

Requirements for Credit

In order to receive credit, the participant must view the entire presentation and complete the pre and post-test, and evaluation. Upon completion participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

Statement of Disclosure

It is the policy of MCPHS-CE to ensure balance, independence, objectivity and scientific rigor in all of its educational activities. All individuals engaged in the planning of a continuing education activity and who are in a position to control the educational content are required to disclose any financial relationships with ineligible companies occurring within the past 24 months. The intent of this policy is to identify and mitigate any potential conflict of interest that may directly or indirectly affect the activity. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.

MCPHS will identify, review and mitigate all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

No funding from industry provided for this event. No exhibitors will be present.
Katie Marti and MCPHS CE staff members hold no financial relationships with ineligible companies, related to the content of this presentation.